Rayner Intraocular Lenses Limited
7
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
28.6%
2 terminated/withdrawn out of 7 trials
33.3%
-53.2% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Outcomes of Cataract & Refractive Procedures
Role: collaborator
Clinical Trial of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Corneal Astigmatism
Role: lead
Post-Market Clinical Follow-Up Study on the Rotational Stability of an Intraocular Lens After Cataract Surgery
Role: lead
Clinical Investigation of the Modified Rayner Monofocal Aspheric 600C (With Axis Marks) Intraocular Lens
Role: lead
Rayner Toric IOL Rotational Stability
Role: collaborator
Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.
Role: collaborator
A Multi Focal Visual Outcome Study Using Different Near Additions
Role: lead
All 7 trials loaded